whitepaper

Application note: Rapidly isolate high-producing clones

Posted: 21 December 2018 | | No comments yet

Find out how to streamline Cell Line Development by identifying high-producing clones with monoclonality assurance in one day.

In the discovery and development of novel biopharmaceuticals (such as antibodies) for therapeutic use Cell Line Development is an integral process in the biomanufacturing of therapeutic proteins. Mammalian cells make ideal factories for protein production as they have similar molecular mechanisms to human cells for protein modifications such as glycosylation.











To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Sphere Fluidics Ltd.

Send this to a friend